PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy
CompletedOBSERVATIONAL
Enrollment
750
Participants
Timeline
Start Date
June 30, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
December 31, 2015
Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG
Metformin
All Listed Sponsors
lead
People's Hospital of Zhengzhou University
OTHER
NCT03155087 - PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy | Biotech Hunter | Biotech Hunter